Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) is now available.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has provided an update regarding the bankruptcy liquidation of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd. As of the latest announcement, there have been no significant developments in the bankruptcy proceedings that would impact the company’s financial position. The company is actively monitoring the situation and will continue to provide monthly updates to safeguard the interests of its shareholders.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
For detailed information about 2TZ stock, go to TipRanks’ Stock Analysis page.